
Biomerica BMRA
€ 1.84
0.0%
Quartalsbericht 2025-Q4
hinzugefügt 14.01.2026
Biomerica EV 2011-2026 | BMRA
EV Jährlich Biomerica
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.63 M | -540 K | 9.29 M | 40.3 M | 46.1 M | 68.1 M | 24.5 M | 33 M | 21.2 M | 10.1 M | 6.99 M | 5.83 M | 3.92 M | 4.34 M | 2.5 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 68.1 M | -540 K | 18.8 M |
EV anderer Aktien in der Diagnostik & Forschung
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | ||
|
Check-Cap Ltd.
CHEK
|
2.55 M | - | - | $ 9.42 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | ||
|
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | ||
|
Aspira Women's Health
AWH
|
42.8 M | - | -6.19 % | $ 10.5 M | ||
|
Co-Diagnostics
CODX
|
29.3 M | $ 4.4 | 101.83 % | $ 129 M | ||
|
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | ||
|
Lantheus Holdings
LNTH
|
5.9 B | $ 74.43 | -1.72 % | $ 5.02 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
Charles River Laboratories International
CRL
|
11.4 B | $ 158.47 | 0.24 % | $ 7.85 B | ||
|
IQVIA Holdings
IQV
|
49.6 B | $ 165.48 | -0.92 % | $ 28.4 B | ||
|
Medpace Holdings
MEDP
|
14 B | $ 457.54 | 0.13 % | $ 13.2 B | ||
|
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | ||
|
Invitae Corporation
NVTA
|
2.11 B | - | - | $ 21.2 M | ||
|
BioNano Genomics
BNGO
|
34.1 M | $ 1.21 | -17.14 % | $ 6.59 M | ||
|
Mettler-Toledo International
MTD
|
32.1 B | $ 1 243.86 | 0.28 % | $ 25.6 B | ||
|
Interpace Biosciences
IDXG
|
19.7 M | $ 1.71 | 0.73 % | $ 7.5 M | ||
|
IDEXX Laboratories
IDXX
|
52.7 B | $ 571.85 | -1.15 % | $ 46 B | ||
|
Illumina
ILMN
|
15.3 B | $ 125.07 | 1.03 % | $ 19.9 B | ||
|
ICON Public Limited Company
ICLR
|
26.4 B | $ 100.54 | 0.19 % | $ 8.29 B | ||
|
Myriad Genetics
MYGN
|
598 M | $ 4.68 | 0.54 % | $ 433 M | ||
|
Guardant Health
GH
|
15.2 B | $ 83.91 | -1.17 % | $ 10.5 B | ||
|
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B | ||
|
National Research Corporation
NRC
|
432 M | $ 17.51 | - | $ 392 M | ||
|
Pacific Biosciences of California
PACB
|
1.21 B | $ 1.36 | -2.52 % | $ 408 M | ||
|
Celcuity
CELC
|
506 M | $ 101.4 | -5.01 % | $ 4 B | ||
|
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | ||
|
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 263.49 | -0.37 % | $ 21.9 B | ||
|
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | ||
|
Precipio
PRPO
|
10.9 M | $ 26.85 | -0.3 % | $ 34.8 M | ||
|
ENDRA Life Sciences
NDRA
|
864 K | $ 3.41 | -2.16 % | $ 1.83 M | ||
|
NeoGenomics
NEO
|
1.85 B | $ 7.93 | -2.1 % | $ 1.02 B | ||
|
Personalis
PSNL
|
229 M | $ 7.52 | -1.18 % | $ 446 M | ||
|
Natera
NTRA
|
5.53 B | $ 194.93 | -2.58 % | $ 19.2 B | ||
|
RadNet
RDNT
|
7.26 B | $ 59.45 | -3.72 % | $ 4.47 B | ||
|
CareDx, Inc
CDNA
|
1.04 B | $ 17.37 | -1.08 % | $ 926 M | ||
|
OPKO Health
OPK
|
1.62 B | $ 1.14 | -1.3 % | $ 791 M | ||
|
Castle Biosciences
CSTL
|
665 M | $ 25.36 | -1.51 % | $ 704 M | ||
|
Senseonics Holdings
SENS
|
376 M | $ 6.71 | 1.36 % | $ 280 M | ||
|
Sotera Health Company
SHC
|
7.07 B | $ 13.8 | -0.61 % | $ 3.92 B | ||
|
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 195.47 | -0.08 % | $ 21.7 B | ||
|
DarioHealth Corp.
DRIO
|
11 M | $ 7.37 | -1.73 % | $ 29.4 M | ||
|
DexCom
DXCM
|
28.2 B | $ 66.5 | 0.85 % | $ 25.9 B |